LifeNet Health Acquires Tissue Testing Technologies (T3)

LifeNet Health Acquires HCM Medical

August 20, 2025

Biotechnology

LifeNet Health has acquired HCM Medical, a Netherlands‑based contract manufacturing organization (CMO) specializing in biologics and tissue‑processing technologies. The deal expands LifeNet Health's manufacturing capabilities in regenerative biologics — including xenograft platforms, antibiotic‑coated implants, and advanced sterilization — to accelerate global access to advanced therapies.

Veranex Acquires T3 Labs

December 13, 2023

Medical Devices

Veranex has acquired T3 Labs, a preclinical laboratory based in Atlanta, Georgia. The acquisition expands Veranex's preclinical footprint in North America and deepens its medical‑device testing and therapeutic expertise to provide more integrated services to medtech clients.

Premier Biotech Acquires National Test Systems

November 5, 2025

Medical Devices

Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.

Tricentis Acquires Tx3 Services

March 1, 2022

Software

Tricentis, the enterprise continuous testing leader, has acquired Tx3 Services, a provider of automated digital validation and compliance testing solutions for life sciences organizations. The acquisition integrates Tx3's life-sciences-focused validation capabilities into Tricentis' AI-powered testing platform to expand capabilities and better serve healthcare and life sciences customers.

Tactile Medical Acquires LymphaTech

February 19, 2026

Medical Devices

Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech, Inc. for an upfront cash payment of $6.8 million plus potential milestone-based consideration to expand its lymphedema solutions into digital and connected care. LymphaTech co-founders joined Tactile to support commercial adoption and R&D as Tactile integrates the company’s 3D measurement and monitoring platform into its portfolio.

Savills Acquires T3 Advisors

June 11, 2021

Real Estate

Savills has acquired T3 Advisors, a U.S.-based real estate and workplace solutions advisory firm that serves life sciences and technology companies. The acquisition expands Savills' capabilities in life sciences and technology tenant representation and strengthens its North American footprint.